Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Deconinck

Showing results (171-180 of 236) with videos related to

Pageof 24
Sort By:
Blood|January 22, 2010
Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistanceCarole Henry, Marina Deschamps, Pierre-Simon Rohrlich, et al.
Cancer Research|December 6, 2018
CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T CellsWalid Warda, Fabrice Larosa, Mathieu Neto Da Rocha, et al.
British Journal of Haematology|April 10, 2021
Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemiaMohamed A Kharfan-Dabaja, Myriam Labopin, Eolia Brissot, et al.
Annals of Hematology|February 16, 2026
Contribution of a specific panel by flow cytometry for the differential diagnosis of plasmacytoid dendritic cell neoplasmsFlorian Renosi, Sabeha Biichlé, Xavier Roussel, et al.
European Journal of Haematology|August 19, 2014
Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC)Thierry Guillaume, Yves Beguin, Reza Tabrizi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 11, 2015
Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation, and the Societé Française de Greffe de Moelle et Therapie CellulaireErick Xavier, Jérôme Cornillon, Annalisa Ruggeri, et al.
Experimental Hematology|March 19, 2008
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie CellulaireMauricette Michallet, Quoc-Hung Le, Mohamad Mohty, et al.
American Journal of Hematology|January 30, 2018
Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic AnemiaRégis Peffault de Latour, Reza Tabrizi, Ambroise Marcais, et al.
Journal of Xenobiotics|June 25, 2025
The Occurrence of Illicit Smart Drugs or Nootropics in Europe and Australia and Their Associated Dangers: Results from a Market Surveillance Study by 12 Official Medicines Control LaboratoriesCeline Vanhee, Eric Deconinck, Mark George, et al.
Bone Marrow Transplantation|October 13, 2020
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMTLeyre Bento, Ariane Boumendil, Hervé Finel, et al.
Pageof 24

Showing results (171-180 of 236) with videos related to

Sort By:
Pageof 24
Blood|January 22, 2010
Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistanceCarole Henry, Marina Deschamps, Pierre-Simon Rohrlich, et al.
Cancer Research|December 6, 2018
CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T CellsWalid Warda, Fabrice Larosa, Mathieu Neto Da Rocha, et al.
British Journal of Haematology|April 10, 2021
Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemiaMohamed A Kharfan-Dabaja, Myriam Labopin, Eolia Brissot, et al.
Annals of Hematology|February 16, 2026
Contribution of a specific panel by flow cytometry for the differential diagnosis of plasmacytoid dendritic cell neoplasmsFlorian Renosi, Sabeha Biichlé, Xavier Roussel, et al.
European Journal of Haematology|August 19, 2014
Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC)Thierry Guillaume, Yves Beguin, Reza Tabrizi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 11, 2015
Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation, and the Societé Française de Greffe de Moelle et Therapie CellulaireErick Xavier, Jérôme Cornillon, Annalisa Ruggeri, et al.
Experimental Hematology|March 19, 2008
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie CellulaireMauricette Michallet, Quoc-Hung Le, Mohamad Mohty, et al.
American Journal of Hematology|January 30, 2018
Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic AnemiaRégis Peffault de Latour, Reza Tabrizi, Ambroise Marcais, et al.
Journal of Xenobiotics|June 25, 2025
The Occurrence of Illicit Smart Drugs or Nootropics in Europe and Australia and Their Associated Dangers: Results from a Market Surveillance Study by 12 Official Medicines Control LaboratoriesCeline Vanhee, Eric Deconinck, Mark George, et al.
Bone Marrow Transplantation|October 13, 2020
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMTLeyre Bento, Ariane Boumendil, Hervé Finel, et al.
Pageof 24